Hamilton Thorne Ltd. (HTLZF)
USD 1.59
(N/A%)
USD 1.59
(N/A%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 45.84 Million USD | 44.44% |
| 2022 | 31.73 Million USD | 66.11% |
| 2021 | 19.1 Million USD | 1.94% |
| 2020 | 18.74 Million USD | -2.51% |
| 2019 | 19.22 Million USD | 33.56% |
| 2018 | 14.39 Million USD | -10.77% |
| 2017 | 16.13 Million USD | 82.49% |
| 2016 | 8.83 Million USD | 61.49% |
| 2015 | 5.47 Million USD | 1.46% |
| 2014 | 5.39 Million USD | -0.94% |
| 2013 | 5.44 Million USD | -3.01% |
| 2012 | 5.61 Million USD | 2.93% |
| 2011 | 5.45 Million USD | -30.65% |
| 2010 | 7.86 Million USD | 23.8% |
| 2009 | 6.35 Million USD | 17576.9% |
| 2008 | 35.94 Thousand USD | 51.3% |
| 2007 | 23.75 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 44.7 Million USD | 2.7% |
| 2024 Q1 | 43.53 Million USD | -5.03% |
| 2023 Q2 | 32.96 Million USD | 12.65% |
| 2023 Q1 | 29.26 Million USD | -7.78% |
| 2023 Q4 | 45.84 Million USD | 32.48% |
| 2023 Q3 | 34.6 Million USD | 4.96% |
| 2023 FY | 45.84 Million USD | 44.44% |
| 2022 FY | 31.73 Million USD | 66.11% |
| 2022 Q2 | 16.3 Million USD | -10.92% |
| 2022 Q3 | 17.49 Million USD | 7.33% |
| 2022 Q4 | 31.73 Million USD | 81.36% |
| 2022 Q1 | 18.3 Million USD | -4.2% |
| 2021 Q3 | 20.84 Million USD | 22.61% |
| 2021 Q2 | 16.99 Million USD | 2.11% |
| 2021 Q1 | 16.64 Million USD | -11.18% |
| 2021 FY | 19.1 Million USD | 1.94% |
| 2021 Q4 | 19.1 Million USD | -8.33% |
| 2020 Q1 | 22.06 Million USD | 14.76% |
| 2020 FY | 18.74 Million USD | -2.51% |
| 2020 Q2 | 17.77 Million USD | -19.44% |
| 2020 Q3 | 18.25 Million USD | 2.7% |
| 2020 Q4 | 18.74 Million USD | 2.68% |
| 2019 Q1 | 18.52 Million USD | 28.7% |
| 2019 Q2 | 16.1 Million USD | -13.09% |
| 2019 Q4 | 19.22 Million USD | 1.23% |
| 2019 FY | 19.22 Million USD | 33.56% |
| 2019 Q3 | 18.99 Million USD | 17.94% |
| 2018 Q1 | 15.71 Million USD | -2.6% |
| 2018 Q4 | 14.39 Million USD | -12.21% |
| 2018 FY | 14.39 Million USD | -10.77% |
| 2018 Q3 | 16.39 Million USD | 3.72% |
| 2018 Q2 | 15.8 Million USD | 0.61% |
| 2017 Q1 | 8.21 Million USD | -7.1% |
| 2017 Q4 | 16.13 Million USD | -0.83% |
| 2017 FY | 16.13 Million USD | 82.49% |
| 2017 Q3 | 16.26 Million USD | -4.35% |
| 2017 Q2 | 17 Million USD | 107.07% |
| 2016 Q1 | 5.46 Million USD | -0.23% |
| 2016 FY | 8.83 Million USD | 61.49% |
| 2016 Q4 | 8.83 Million USD | -3.96% |
| 2016 Q2 | 5.72 Million USD | 4.75% |
| 2016 Q3 | 9.2 Million USD | 60.89% |
| 2015 Q1 | 5.39 Million USD | -0.08% |
| 2015 FY | 5.47 Million USD | 1.46% |
| 2015 Q2 | 5.58 Million USD | 3.51% |
| 2015 Q4 | 5.47 Million USD | -0.71% |
| 2015 Q3 | 5.51 Million USD | -1.21% |
| 2014 Q1 | 5.45 Million USD | 0.2% |
| 2014 FY | 5.39 Million USD | -0.94% |
| 2014 Q3 | 5.14 Million USD | -1.78% |
| 2014 Q4 | 5.39 Million USD | 4.87% |
| 2014 Q2 | 5.23 Million USD | -4.02% |
| 2013 Q4 | 5.44 Million USD | 0.54% |
| 2013 FY | 5.44 Million USD | -3.01% |
| 2013 Q1 | 5.52 Million USD | -1.69% |
| 2013 Q2 | 5.61 Million USD | 1.69% |
| 2013 Q3 | 5.41 Million USD | -3.5% |
| 2012 Q3 | 5.51 Million USD | 0.32% |
| 2012 Q4 | 5.61 Million USD | 1.88% |
| 2012 Q2 | 5.49 Million USD | 0.39% |
| 2012 Q1 | 5.47 Million USD | 0.32% |
| 2012 FY | 5.61 Million USD | 2.93% |
| 2011 Q2 | 8.74 Million USD | 2.74% |
| 2011 FY | 5.45 Million USD | -30.65% |
| 2011 Q4 | 5.45 Million USD | 0.76% |
| 2011 Q3 | 5.41 Million USD | -38.08% |
| 2011 Q1 | 8.51 Million USD | 8.2% |
| 2010 Q4 | 7.86 Million USD | 3.51% |
| 2010 Q1 | 6.33 Million USD | -0.32% |
| 2010 FY | 7.86 Million USD | 23.8% |
| 2010 Q3 | 7.59 Million USD | 16.79% |
| 2010 Q2 | 6.5 Million USD | 2.74% |
| 2009 Q3 | 9.4 Million USD | 9.47% |
| 2009 Q2 | 8.59 Million USD | 72665.88% |
| 2009 Q1 | 11.81 Thousand USD | -67.15% |
| 2009 FY | 6.35 Million USD | 17576.9% |
| 2009 Q4 | 6.35 Million USD | -32.46% |
| 2008 Q1 | 31.88 Thousand USD | 34.22% |
| 2008 Q3 | 4998.75 USD | -96.78% |
| 2008 Q4 | 35.94 Thousand USD | 619.1% |
| 2008 FY | 35.94 Thousand USD | 51.3% |
| 2008 Q2 | 155.28 Thousand USD | 386.95% |
| 2007 Q4 | 23.75 Thousand USD | 81.83% |
| 2007 Q3 | 13.06 Thousand USD | -85.25% |
| 2007 FY | 23.75 Thousand USD | 0.0% |
| 2007 Q2 | 88.56 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Avitar, Inc. | 11.59 Million USD | -295.417% |
| BioElectronics Corporation | 16.62 Million USD | -175.783% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 634 Thousand USD | -7130.73% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -6665.311% |
| Polarean Imaging plc | 2.58 Million USD | -1676.483% |
| AVITA Medical, Inc. | 19.86 Million USD | -130.767% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | -2064.439% |
| Össur hf. | 688.8 Million USD | 93.345% |
| Zecotek Photonics Inc. | 5.86 Million USD | -681.154% |
| QHSLab, Inc. | 2.05 Million USD | -2128.572% |
| Wellstar International, Inc. | 55.99 Million USD | 18.124% |
| Össur hf. | 688.8 Million USD | 93.345% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | -185.083% |
| Escalon Medical Corp. | 2.94 Million USD | -1454.867% |
| Aurora Spine Corporation | 6.65 Million USD | -588.999% |
| BrainsWay Ltd. | 15.31 Million USD | -199.352% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 6.01 Million USD | -662.44% |
| Vivos Inc. | 245 Thousand USD | -18611.052% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 98.156% |
| Kelyniam Global, Inc. | 1.01 Million USD | -4425.742% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -16532.982% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | -1771.282% |
| Nanomix Corporation | 14.81 Million USD | -209.44% |
| Theraclion SA | 13.01 Million EUR | -252.188% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | -794.634% |
| Positron Corporation | 2.02 Million USD | -2162.728% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | -1165.967% |
| Lombard Medical, Inc. | 53.79 Million USD | 14.781% |
| ALR Technologies Inc. | 24.5 Million USD | -87.073% |
| Stratec SE | 271.97 Million USD | 83.144% |
| Vycor Medical, Inc. | 4.31 Million USD | -961.724% |
| Heart Tronics, Inc. | 1.09 Million USD | -4087.366% |
| Nu-Med Plus, Inc. | 2.35 Million USD | -1843.492% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | -737.072% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 30.111% |
| VMS Rehab Systems, Inc. | 201.36 USD | -22766500.616% |
| Guided Therapeutics, Inc. | 5.47 Million USD | -737.312% |
| Ingen Technologies, Inc. | 5.7 Million USD | -702.915% |
| Odyssey Group International, Inc. | 6.61 Million USD | -593.357% |
| United American Healthcare Corporation | 119 Thousand USD | -38423.384% |
| ECGI Holdings, Inc. | 11.94 Million USD | -283.932% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -3362.491% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -3069.581% |
| Urologix, Inc. | 12.64 Million USD | -262.566% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -749.561% |
| Nexeon MedSystems Inc. | 8.48 Million USD | -440.443% |
| SS Innovations International, Inc. | 11.18 Million USD | -310.003% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -8625.535% |
| Smith & Nephew plc | 4.76 Billion USD | 99.038% |
| NIOX Group Plc | 9.8 Million USD | -367.684% |
| Fuse Medical, Inc. | 15.11 Million USD | -203.393% |
| Broncus Holding Corporation | 10.43 Million USD | -339.437% |
| Brain Scientific Inc. | 7.42 Million USD | -517.295% |
| Pressure BioSciences, Inc. | 33.8 Million USD | -35.616% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -5673.067% |